accession	uid	title	organization	taxonomy	sra	geo	Sex	brca mutation	cell line	kinase mutation	source_name	tp53 mutation	treatment
SAMN18490632	18490632	OVCAR4_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575304	GSM5211117	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490633	18490633	TYKnu_Baseline_flowcell 1	University of Newcastle	9606	SRS8575297	GSM5211110	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Untreated
SAMN18490634	18490634	OVCAR4_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575296	GSM5211109	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490635	18490635	OVCAR4_Baseline_flowcell 1	University of Newcastle	9606	SRS8575295	GSM5211108	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Untreated
SAMN18490636	18490636	OAW28_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575294	GSM5211107	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490637	18490637	OAW28_Baseline_flowcell 1	University of Newcastle	9606	SRS8575293	GSM5211106	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Untreated
SAMN18490638	18490638	COV362_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575292	GSM5211105	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490639	18490639	COV362_Baseline_flowcell 1	University of Newcastle	9606	SRS8575291	GSM5211104	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Untreated
SAMN18490648	18490648	TYKnu_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575307	GSM5211119	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490649	18490649	TYKnu_Untreated_flowcell 2	University of Newcastle	9606	SRS8575305	GSM5211118	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Untreated
SAMN18490650	18490650	OVCAR4_Untreated_flowcell 2	University of Newcastle	9606	SRS8575303	GSM5211116	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Untreated
SAMN18490651	18490651	OAW28_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575302	GSM5211115	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490652	18490652	OAW28_Untreated_flowcell 2	University of Newcastle	9606	SRS8575300	GSM5211114	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Untreated
SAMN18490653	18490653	COV362_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575299	GSM5211113	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490654	18490654	COV362_Untreated_flowcell 2	University of Newcastle	9606	SRS8575301	GSM5211112	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Untreated
SAMN18490655	18490655	TYKnu_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575298	GSM5211111	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Treated with 5µM azacitidine and 20µM carboplatin
